Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

Andre Abitbol; Alan Lewin; Michael Troner; Maria-Amelia Rodrigues

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	International Journal of Radiation Oncology, Biology, Physics
Volume	53
State	Published - Jul 15 2002

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol. / Abitbol, Andre ; Lewin, Alan; Troner, Michael et al.
In: International Journal of Radiation Oncology, Biology, Physics, Vol. 53, 15.07.2002.

Research output: Contribution to journal › Article › peer-review

Abitbol, Andre ; Lewin, Alan ; Troner, Michael et al. / Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol. In: International Journal of Radiation Oncology, Biology, Physics. 2002 ; Vol. 53.

@article{af86be244c5340169690200c538bf41f,

title = "Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol",

author = "Andre Abitbol and Alan Lewin and Michael Troner and Maria-Amelia Rodrigues",

note = "International Journal of Radiation Oncology, Biology, Physics (2002) 53(4):942-7",

year = "2002",

month = jul,

day = "15",

language = "American English",

volume = "53",

journal = "International Journal of Radiation Oncology, Biology, Physics",

}

TY - JOUR

T1 - Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

AU - Abitbol, Andre

AU - Lewin, Alan

AU - Troner, Michael

AU - Rodrigues, Maria-Amelia

N1 - International Journal of Radiation Oncology, Biology, Physics (2002) 53(4):942-7

PY - 2002/7/15

Y1 - 2002/7/15

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/2014

M3 - Article

VL - 53

JO - International Journal of Radiation Oncology, Biology, Physics

JF - International Journal of Radiation Oncology, Biology, Physics

ER -

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

Access to Document

Other files and links

Cite this